Clinical Edge Journal Scan

Children with atopic dermatitis more prone to allergic contact dermatitis


 

Key clinical point: Compared with children without atopic dermatitis (AD), those with AD are significantly more likely to have positive patch tests (PPT) and respond to ≥1 allergen on patch testing.

Major finding: Children with vs without AD were significantly more likely to have a longer duration of dermatitis ( P < .0001), >1 PPT result ( P = .005), a greater number of PPT overall ( P = .012), and a more generalized distribution of dermatitis ( P = .001) as well as PPT to bacitracin ( P = .030), carba mix (diphenylguanidine, zinc dibutyldithiocarbamate, and zinc diethyldithiocarbamate) ( P = .025), and cocamidopropyl betaine ( P = .0007).

Study details: This retrospective case-control study included 615 children with AD and 297 children without AD.

Disclosures: This study was supported by the Dermatology Foundation, Evanston, IL. The authors declared no conflicts of interest.

Source: Johnson H et al. Prevalence of allergic contact dermatitis in children with and without atopic dermatitis: A multicenter retrospective case-control study. J Am Acad Dermatol. 2023;89(5):1007-1014 (Sep 25). doi: 10.1016/j.jaad.2023.06.048

Recommended Reading

Upadacitinib an effective treatment option in AD patients with recent discontinuation of dupilumab
MDedge Dermatology
CHMP recommends marketing of biologic for atopic dermatitis
MDedge Dermatology
Commentary: Are "significant" results necessarily clinically meaningful? October 2023
MDedge Dermatology
Concurrent Atopic Dermatitis and Psoriasis Successfully Treated With Dual Biologic Therapy
MDedge Dermatology
Study finds inflammatory bowel disease risk higher in children, adults with atopic dermatitis
MDedge Dermatology
FDA issues letter regarding lebrikizumab review for atopic dermatitis
MDedge Dermatology
What’s Eating You? Noble False Widow Spider (Steatoda nobilis)
MDedge Dermatology
Patch testing finds higher prevalence of ACD among children with AD
MDedge Dermatology
Topical botanical drug coacillium curbs childhood alopecia
MDedge Dermatology
Atopic Dermatitis Triggered by Omalizumab and Treated With Dupilumab
MDedge Dermatology